Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
Title:
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome
Author:
Oriol-Tordera, Bruna Esteve-Codina, Anna Berdasco, María Rosás-Umbert, Míriam Gonçalves, Elena Duran-Castells, Clara Català-Moll, Francesc Llano, Anuska Cedeño, Samandhy Puertas, Maria C. Tolstrup, Martin Søgaard, Ole S. Clotet, Bonaventura Martínez-Picado, Javier Hanke, Tomáš Combadiere, Behazine Paredes, Roger Hartigan-O'Connor, Dennis Esteller, Manel Meulbroek, Michael Calle, María Luz Sanchez-Pla, Alex Moltó, José Mothe, Beatriz Brander, Christian Ruiz-Riol, Marta